Method of using insulin for controlling glycosylation of recombinant glycoprotein
The present invention relates to a method for controlling a glycosylation pattern of a recombinant glycoprotein, comprising culturing a cell comprising polynucleotide encoding a recombinant glycoprotein in a culture medium comprising insulin.
1. A method for controlling a glycosylation pattern of a recombinant glycoprotein, comprising culturing a microorganism comprising a polynucleotide encoding the recombinant glycoprotein in a culture medium comprising insulin, wherein said insulin is in an amount sufficient to reduce any N-glycans and/or O-glycans on said recombinant glycoprotein.
2. The method of claim 1 , wherein the recombinant glycoprotein is an immunoglobulin fusion protein.
3. The method of claim 1 , wherein the recombinant glycoprotein is a Tumor Necrosis Factor Receptor (TNFR)-Fc fusion protein.
4. The method of claim 1 , wherein a concentration of the insulin is 0.0001 mg/L to 1 g/L relative to the total volume of the culture medium.
5. The method of claim 1 , wherein the insulin controls N-linked glycosylation and O-linked glycosylation.
6. The method of claim 1 , wherein the insulin reduces any N-glycan content of the recombinant glycoprotein.
7. The method of claim 1 , wherein the insulin reduces any O-glycan content of the recombinant glycoprotein.
8. The method of claim 1 , wherein the culturing is a perfusion culturing method.
9. A method for controlling a glycosylation pattern of a recombinant glycoprotein, comprising:
(a) culturing a microorganism comprising a polynucleotide encoding a recombinant glycoprotein in a culture medium to grow the microorganism; and
(b) adding insulin to the culture medium and culturing the same to produce a glycoprotein, wherein said insulin is added in an amount sufficient to reduce any N-glycans and/or O-glycans on said recombinant glycoprotein.
10. The method of claim 9 , wherein said insulin is added at different concentrations to produce a target glycosylation pattern.
11. The method of claim 10 , wherein the insulin is added in an amount sufficient to reduce the amount of any N-glycan or O-glycan on the recombinant glycoprotein.
12. The method of claim 9 , wherein the recombinant glycoprotein is an immunoglobulin fusion protein.
13. The method of claim 9 , wherein the recombinant glycoprotein is a TNFR-Fc fusion protein.
14. The method of claim 9 , wherein a concentration of the insulin is 0.0001 mg/L to 1 g/L relative to the total volume of the culture medium.
15. The method of claim 9 , wherein the culturing is a perfusion culturing method.